Frontlight ResearchEarly access
Trial site
Mount Sinai Braman Comprehensive Cancer Center
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 33 trials
- Status
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Eli Lilly and Company1 trial
- Revolution Medicines, Inc.1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
Running trials
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026